Source: International Business Times
Moderna's shares fell 25% on Thursday after details of its cancer vaccine got leaked ahead of its presentation. Getty Images Moderna's shares plunged on Thursday after data of its breakthrough cancer vaccine developed with Merck got leaked online. The stock fell up to 25% in the afternoon even though the information was positive compared to what was expected by analysts.
Aller á la Source
Nouvelles connexes
